Swedish Cancer Society Radiation Therapy Research Investigation

Authors

  • Sören Mattsson From the Department of Radiation Physics, Malmo University Hospital, Malmo (S. Mattsson), Departments of Medical Radiation Physics (A. Brahme) and Oncology and Pathology (B. Glimelius), Karolinska Institutet, Stockholm, Department of Oncology, Radiology and Clinical Immunology, Uppsala University, Uppsala (J. Carlsson, B. Stenerlow, I. Turesson, B. Glimelius), Department of Oncology, Umea University, Umea(J. Denekamp, B. Littbrand, B. Zackrisson), Departments of Radiation Physics (E. ForssellAronsson, K.A. Johansson) and Diagnostic Radiology (M. Hellstrom), Goteborg University, Department of Oncology, University Hospital, Lund (E. Kjellen), Department of Oncology,University Hospital, Linkoping (B. Nordenskjold), Sweden
  • Anders Brahme From the Department of Radiation Physics, Malmo University Hospital, Malmo (S. Mattsson), Departments of Medical Radiation Physics (A. Brahme) and Oncology and Pathology (B. Glimelius), Karolinska Institutet, Stockholm, Department of Oncology, Radiology and Clinical Immunology, Uppsala University, Uppsala (J. Carlsson, B. Stenerlow, I. Turesson, B. Glimelius), Department of Oncology, Umea University, Umea(J. Denekamp, B. Littbrand, B. Zackrisson), Departments of Radiation Physics (E. ForssellAronsson, K.A. Johansson) and Diagnostic Radiology (M. Hellstrom), Goteborg University, Department of Oncology, University Hospital, Lund (E. Kjellen), Department of Oncology,University Hospital, Linkoping (B. Nordenskjold), Sweden
  • Jörgen Carlsson From the Department of Radiation Physics, Malmo University Hospital, Malmo (S. Mattsson), Departments of Medical Radiation Physics (A. Brahme) and Oncology and Pathology (B. Glimelius), Karolinska Institutet, Stockholm, Department of Oncology, Radiology and Clinical Immunology, Uppsala University, Uppsala (J. Carlsson, B. Stenerlow, I. Turesson, B. Glimelius), Department of Oncology, Umea University, Umea(J. Denekamp, B. Littbrand, B. Zackrisson), Departments of Radiation Physics (E. ForssellAronsson, K.A. Johansson) and Diagnostic Radiology (M. Hellstrom), Goteborg University, Department of Oncology, University Hospital, Lund (E. Kjellen), Department of Oncology,University Hospital, Linkoping (B. Nordenskjold), Sweden
  • Juliana Denekamp From the Department of Radiation Physics, Malmo University Hospital, Malmo (S. Mattsson), Departments of Medical Radiation Physics (A. Brahme) and Oncology and Pathology (B. Glimelius), Karolinska Institutet, Stockholm, Department of Oncology, Radiology and Clinical Immunology, Uppsala University, Uppsala (J. Carlsson, B. Stenerlow, I. Turesson, B. Glimelius), Department of Oncology, Umea University, Umea(J. Denekamp, B. Littbrand, B. Zackrisson), Departments of Radiation Physics (E. ForssellAronsson, K.A. Johansson) and Diagnostic Radiology (M. Hellstrom), Goteborg University, Department of Oncology, University Hospital, Lund (E. Kjellen), Department of Oncology,University Hospital, Linkoping (B. Nordenskjold), Sweden
  • Eva Forssell-Aronsson From the Department of Radiation Physics, Malmo University Hospital, Malmo (S. Mattsson), Departments of Medical Radiation Physics (A. Brahme) and Oncology and Pathology (B. Glimelius), Karolinska Institutet, Stockholm, Department of Oncology, Radiology and Clinical Immunology, Uppsala University, Uppsala (J. Carlsson, B. Stenerlow, I. Turesson, B. Glimelius), Department of Oncology, Umea University, Umea(J. Denekamp, B. Littbrand, B. Zackrisson), Departments of Radiation Physics (E. ForssellAronsson, K.A. Johansson) and Diagnostic Radiology (M. Hellstrom), Goteborg University, Department of Oncology, University Hospital, Lund (E. Kjellen), Department of Oncology,University Hospital, Linkoping (B. Nordenskjold), Sweden
  • Mikael Hellström From the Department of Radiation Physics, Malmo University Hospital, Malmo (S. Mattsson), Departments of Medical Radiation Physics (A. Brahme) and Oncology and Pathology (B. Glimelius), Karolinska Institutet, Stockholm, Department of Oncology, Radiology and Clinical Immunology, Uppsala University, Uppsala (J. Carlsson, B. Stenerlow, I. Turesson, B. Glimelius), Department of Oncology, Umea University, Umea(J. Denekamp, B. Littbrand, B. Zackrisson), Departments of Radiation Physics (E. ForssellAronsson, K.A. Johansson) and Diagnostic Radiology (M. Hellstrom), Goteborg University, Department of Oncology, University Hospital, Lund (E. Kjellen), Department of Oncology,University Hospital, Linkoping (B. Nordenskjold), Sweden
  • Karl-Axel Johansson From the Department of Radiation Physics, Malmo University Hospital, Malmo (S. Mattsson), Departments of Medical Radiation Physics (A. Brahme) and Oncology and Pathology (B. Glimelius), Karolinska Institutet, Stockholm, Department of Oncology, Radiology and Clinical Immunology, Uppsala University, Uppsala (J. Carlsson, B. Stenerlow, I. Turesson, B. Glimelius), Department of Oncology, Umea University, Umea(J. Denekamp, B. Littbrand, B. Zackrisson), Departments of Radiation Physics (E. ForssellAronsson, K.A. Johansson) and Diagnostic Radiology (M. Hellstrom), Goteborg University, Department of Oncology, University Hospital, Lund (E. Kjellen), Department of Oncology,University Hospital, Linkoping (B. Nordenskjold), Sweden
  • Elisabeth Kjellén From the Department of Radiation Physics, Malmo University Hospital, Malmo (S. Mattsson), Departments of Medical Radiation Physics (A. Brahme) and Oncology and Pathology (B. Glimelius), Karolinska Institutet, Stockholm, Department of Oncology, Radiology and Clinical Immunology, Uppsala University, Uppsala (J. Carlsson, B. Stenerlow, I. Turesson, B. Glimelius), Department of Oncology, Umea University, Umea(J. Denekamp, B. Littbrand, B. Zackrisson), Departments of Radiation Physics (E. ForssellAronsson, K.A. Johansson) and Diagnostic Radiology (M. Hellstrom), Goteborg University, Department of Oncology, University Hospital, Lund (E. Kjellen), Department of Oncology,University Hospital, Linkoping (B. Nordenskjold), Sweden
  • Bo Littbrand From the Department of Radiation Physics, Malmo University Hospital, Malmo (S. Mattsson), Departments of Medical Radiation Physics (A. Brahme) and Oncology and Pathology (B. Glimelius), Karolinska Institutet, Stockholm, Department of Oncology, Radiology and Clinical Immunology, Uppsala University, Uppsala (J. Carlsson, B. Stenerlow, I. Turesson, B. Glimelius), Department of Oncology, Umea University, Umea(J. Denekamp, B. Littbrand, B. Zackrisson), Departments of Radiation Physics (E. ForssellAronsson, K.A. Johansson) and Diagnostic Radiology (M. Hellstrom), Goteborg University, Department of Oncology, University Hospital, Lund (E. Kjellen), Department of Oncology,University Hospital, Linkoping (B. Nordenskjold), Sweden
  • Bo Nordenskjöld From the Department of Radiation Physics, Malmo University Hospital, Malmo (S. Mattsson), Departments of Medical Radiation Physics (A. Brahme) and Oncology and Pathology (B. Glimelius), Karolinska Institutet, Stockholm, Department of Oncology, Radiology and Clinical Immunology, Uppsala University, Uppsala (J. Carlsson, B. Stenerlow, I. Turesson, B. Glimelius), Department of Oncology, Umea University, Umea(J. Denekamp, B. Littbrand, B. Zackrisson), Departments of Radiation Physics (E. ForssellAronsson, K.A. Johansson) and Diagnostic Radiology (M. Hellstrom), Goteborg University, Department of Oncology, University Hospital, Lund (E. Kjellen), Department of Oncology,University Hospital, Linkoping (B. Nordenskjold), Sweden
  • Bo Stenerlöw From the Department of Radiation Physics, Malmo University Hospital, Malmo (S. Mattsson), Departments of Medical Radiation Physics (A. Brahme) and Oncology and Pathology (B. Glimelius), Karolinska Institutet, Stockholm, Department of Oncology, Radiology and Clinical Immunology, Uppsala University, Uppsala (J. Carlsson, B. Stenerlow, I. Turesson, B. Glimelius), Department of Oncology, Umea University, Umea(J. Denekamp, B. Littbrand, B. Zackrisson), Departments of Radiation Physics (E. ForssellAronsson, K.A. Johansson) and Diagnostic Radiology (M. Hellstrom), Goteborg University, Department of Oncology, University Hospital, Lund (E. Kjellen), Department of Oncology,University Hospital, Linkoping (B. Nordenskjold), Sweden
  • Ingela Turesson From the Department of Radiation Physics, Malmo University Hospital, Malmo (S. Mattsson), Departments of Medical Radiation Physics (A. Brahme) and Oncology and Pathology (B. Glimelius), Karolinska Institutet, Stockholm, Department of Oncology, Radiology and Clinical Immunology, Uppsala University, Uppsala (J. Carlsson, B. Stenerlow, I. Turesson, B. Glimelius), Department of Oncology, Umea University, Umea(J. Denekamp, B. Littbrand, B. Zackrisson), Departments of Radiation Physics (E. ForssellAronsson, K.A. Johansson) and Diagnostic Radiology (M. Hellstrom), Goteborg University, Department of Oncology, University Hospital, Lund (E. Kjellen), Department of Oncology,University Hospital, Linkoping (B. Nordenskjold), Sweden
  • Björn Zackrisson From the Department of Radiation Physics, Malmo University Hospital, Malmo (S. Mattsson), Departments of Medical Radiation Physics (A. Brahme) and Oncology and Pathology (B. Glimelius), Karolinska Institutet, Stockholm, Department of Oncology, Radiology and Clinical Immunology, Uppsala University, Uppsala (J. Carlsson, B. Stenerlow, I. Turesson, B. Glimelius), Department of Oncology, Umea University, Umea(J. Denekamp, B. Littbrand, B. Zackrisson), Departments of Radiation Physics (E. ForssellAronsson, K.A. Johansson) and Diagnostic Radiology (M. Hellstrom), Goteborg University, Department of Oncology, University Hospital, Lund (E. Kjellen), Department of Oncology,University Hospital, Linkoping (B. Nordenskjold), Sweden
  • Bengt Glimelius From the Department of Radiation Physics, Malmo University Hospital, Malmo (S. Mattsson), Departments of Medical Radiation Physics (A. Brahme) and Oncology and Pathology (B. Glimelius), Karolinska Institutet, Stockholm, Department of Oncology, Radiology and Clinical Immunology, Uppsala University, Uppsala (J. Carlsson, B. Stenerlow, I. Turesson, B. Glimelius), Department of Oncology, Umea University, Umea(J. Denekamp, B. Littbrand, B. Zackrisson), Departments of Radiation Physics (E. ForssellAronsson, K.A. Johansson) and Diagnostic Radiology (M. Hellstrom), Goteborg University, Department of Oncology, University Hospital, Lund (E. Kjellen), Department of Oncology,University Hospital, Linkoping (B. Nordenskjold), Sweden

DOI:

https://doi.org/10.1080/028418602321028193

Abstract

In an investigation by the Swedish Cancer Society, the present status, critical issues and future aspects and prospects were described by an expert group for each of nine major areas of radiation research. A summary of the investigation is presented in this report. A more extensive summary (in Swedish) can be found at www.Cancerfonden.se. It is concluded that radiation therapy plays an increasingly important role in curative and palliative tumour treatment and presents a considerable challenge to research. Several suggestions are made that could improve the possibilities for high-quality radiation therapy research in Sweden.

Downloads

Download data is not yet available.

Downloads

Published

2002-01-01

How to Cite

Mattsson, S., Brahme, A., Carlsson, J., Denekamp, J., Forssell-Aronsson, E., Hellström, M., … Glimelius, B. (2002). Swedish Cancer Society Radiation Therapy Research Investigation. Acta Oncologica, 41(7-8), 596–603. https://doi.org/10.1080/028418602321028193

Issue

Vol. 41 No. 7-8 (2002): Acta Oncologica

Section

Articles